Heart Failure Definition Shifts Beyond Ejection Fraction

What Is Changing In The Definition Of Heart Failure?

Heart failure has long been grouped by left ventricular ejection fraction, a useful but imperfect measure of how much blood the left ventricle pumps with each beat. Patients have traditionally been categorized as having reduced, mildly reduced, or preserved ejection fraction, but symptoms, congestion, biomarkers, structural heart disease, and exercise limitation often tell a more complete clinical story.

The updated consensus reported by MedPage Today reflects a broader movement already visible in major cardiology guidance: diagnosis should integrate symptoms such as breathlessness and fatigue, signs such as fluid retention, natriuretic peptide testing, and imaging evidence of cardiac dysfunction. This matters especially for patients whose ejection fraction is not severely reduced but who still have high hospitalization risk and may benefit from guideline-directed treatment.

Why Does Moving Beyond Ejection Fraction Matter For Treatment?

Ejection fraction remains important, but it is not the whole disease. The 2022 AHA/ACC/HFSA heart failure guideline expanded evidence-based treatment discussions across the ejection fraction spectrum, including strong roles for sodium-glucose cotransporter 2 inhibitors in symptomatic chronic heart failure. That shift made the limitations of rigid ejection fraction categories more clinically important.

A broader definition may also improve trial enrollment and interpretation. Many heart failure studies historically used strict ejection fraction thresholds, which can exclude patients who have congestion, elevated natriuretic peptides, or structural heart disease but fall just outside a numerical cutoff. More flexible definitions could make research populations more representative of everyday cardiology practice.

How Could This Affect Patients With Preserved Ejection Fraction?

Heart failure with preserved ejection fraction is common in older adults and in people with hypertension, obesity, diabetes, atrial fibrillation, kidney disease, or other chronic conditions. These patients may have severe symptoms even when the pumping percentage appears normal, because stiffness, filling pressure, vascular disease, inflammation, and metabolic dysfunction can all contribute to reduced cardiac reserve.

For patients, the practical message is not that ejection fraction is obsolete, but that it should be interpreted in context. A careful evaluation may include echocardiography, natriuretic peptide levels, kidney function, medication review, blood pressure control, and assessment for ischemic heart disease or valve disease. Treatment still depends on the individual diagnosis, but a syndrome-based definition may reduce the chance that symptomatic patients are dismissed because one measurement looks reassuring.